Journal of Clinical Oncology , 0732-183X
Journal
Publications
- 2020
- E-pub ahead of print
Augmented reduced-intensity regimen does not improve postallogeneic transplant outcomes in acute myeloid leukemia
Charles Craddock, Aimee Jackson, Justin Loke, Ram Malladi, Keith Wheatley & 7 others, , 29 Dec 2020, In: Journal of Clinical Oncology . 12 p., JCO2002308.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses
Sylvie Freeman, 23 Dec 2020, In: Journal of Clinical Oncology . p. JCO2001170Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study
Aneel Bhangu, 6 Oct 2020, In: Journal of Clinical Oncology . 14 p., JCO2001933.Research output: Contribution to journal › Article › peer-review
- Published
De-escalation after DE-ESCALATE and RTOG 1016: a head and neck cancer InterGroup framework for future de-escalation studies
Hisham Mehanna, 1 Aug 2020, In: Journal of Clinical Oncology . 38, 22, p. 2552-2557 7 p.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials
Daniel Rea, 24 Jul 2020, In: Journal of Clinical Oncology . p. JCO1902427Research output: Contribution to journal › Article › peer-review
- Published
Less is not necessarily more: toward a rational selection of the conditioning regimen in acute myeloid leukemia
Sylvie Freeman, 20 Apr 2020, In: Journal of Clinical Oncology . 38, 12, p. 1249-1251 3 p.Research output: Contribution to journal › Editorial
- Published
ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).
Simon Bach, 2020, In: Journal of Clinical Oncology . p. 4101-410 9 p.Research output: Contribution to journal › Article › peer-review
- 2019
- Published
Ibrutinib plus venetoclax in relapsed/refractory chronic lymphocytic leukemia: the CLARITY study
Kristian Brock, Sam Munoz Vicente, Becky Boucher, 20 Oct 2019, In: Journal of Clinical Oncology . 37, 30, p. 2722-2729 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Trans-aTTom: Breast Cancer Index for prediction of endocrine benefit and late distant recurrence (DR) in patients with HR+ breast cancer treated in the adjuvant tamoxifen—To offer more? (aTTom) trial.
Ikhlaaq Ahmed, Sarah Pirrie & Daniel Rea, 20 May 2019, In: Journal of Clinical Oncology. 37, 15_suppl, p. 505 1 p.Research output: Contribution to journal › Abstract › peer-review
- Published
Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia
Charles Craddock, Daniel Slade, Carmela De Santo, Rachel Hoare, Kristian Brock & Christina Yap, 1 Mar 2019, In: Journal of Clinical Oncology . 37, 7, p. 580-588 9 p., JCO1800889.Research output: Contribution to journal › Article › peer-review
- Published
High-dose chemotherapy compared with standard chemotherapy and lung radiation in ewing sarcoma with pulmonary metastases: Results of the european ewing tumour working initiative of national groups, 99 trial and ewing 2008
& 22 others, , 1 Jan 2019, In: Journal of Clinical Oncology. 37, 34, p. 3192-3202 11 p.Research output: Contribution to journal › Article › peer-review
- 2018
- E-pub ahead of print
High-dose chemotherapy and blood autologous stem-cell rescue compared with standard chemotherapy in localized high-risk Ewing sarcoma: results of Euro-E.W.I.N.G.99 and Ewing-2008
6 Sep 2018, In: Journal of Clinical Oncology . 16 p.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features
Keith Wheatley, 28 Aug 2018, In: Journal of Clinical Oncology .Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Risk, risk factors and surveillance of subsequent malignant neoplasms in childhood cancer survivors: a review
Raoul Reulen, 6 Jun 2018, In: Journal of Clinical Oncology . 36, 9 p.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Development and validation of a combined metabolic and immune prognostic classifier for head and neck cancer
Jill Brooks, Lucinda Archer, Rachel Spruce, Nikos Batis, Jennifer Bryant, Andrew Beggs, Daniel Tennant, Gary Middleton, Jean-Baptiste Cazier, Benjamin Willcox, 1 Jun 2018, In: Journal of Clinical Oncology. 36, 15 Suppl, p. 6049-6049Research output: Contribution to journal › Abstract › peer-review
- Published
Measurable residual disease at induction redefines partial response in acute myeloid leukemia and stratifies outcomes in patients at standard risk without NPM1 mutations
Sylvie Freeman, Naeem Khan, 20 May 2018, In: Journal of Clinical Oncology . 36, 15, p. 1486-1497 12 p.Research output: Contribution to journal › Article › peer-review
- Published
Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: results from a phase II trial
Pamela Kearns, 1 May 2018, In: Journal of Clinical Oncology . 36, 13, p. 1330-1338 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A pooled analysis of individual patient data
& 12 others, , 1 Apr 2018, In: Journal of Clinical Oncology. 36, 10, p. 981-990 10 p.Research output: Contribution to journal › Article › peer-review
- Published
Results of POUT: A phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC)
9 Feb 2018, In: Journal of Clinical Oncology . 36, Suppl 6S, Abstract 407.Research output: Contribution to journal › Abstract › peer-review
- 2017
- Published
Improving outcomes in high-risk Myelodysplasia: Festina Lente
Charles Craddock, 26 May 2017, In: Journal of Clinical Oncology . p. JCO2017730812Research output: Contribution to journal › Editorial › peer-review
- E-pub ahead of print
Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)
Gary Middleton, 27 Feb 2017, In: Journal of Clinical Oncology .Research output: Contribution to journal › Article › peer-review
Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials
20 Feb 2017, In: Journal of Clinical Oncology . 35, 6, p. 622-628 7 p.Research output: Contribution to journal › Article › peer-review
- Published
Randomized prospective biomarker trial of ERCC1 for comparing platinum and nonplatinum therapy in advanced non-small-cell lung cancer: ERCC1 Trial (ET)
Gary Middleton, David Ferry & 3 others, , 1 Feb 2017, In: Journal of Clinical Oncology . 35, 4, p. 402-411 10 p.Research output: Contribution to journal › Article › peer-review
- 2016
- Published
Risk of Adverse Health and Social Outcomes Up to 50 Years After Wilms Tumor: The British Childhood Cancer Survivor Study
Raoul Reulen, Emma Lancashire & Michael Hawkins, 20 May 2016, In: Journal of Clinical Oncology . 34, 15, p. 1772-1779Research output: Contribution to journal › Article › peer-review
- 2015
- Published
Postoperative adjuvant lapatinib and concurrent chemoradiotherapy followed by maintenance lapatinib monotherapy in high-risk patients with resected squamous cell carcinoma of the head and neck: a phase III, randomized, double-blind, placebo-controlled study
Hisham Mehanna & 5 others, , 10 Dec 2015, In: Journal of Clinical Oncology . 33, 35, p. 4202-4209Research output: Contribution to journal › Article › peer-review
- Published
Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study
Charles Craddock, 1 Oct 2015, In: Journal of Clinical Oncology . 33, 28, p. 3144-51 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Collaborative Research in Childhood Cancer Survivorship: The Current Landscape
Michael Hawkins, 20 Sep 2015, In: Journal of Clinical Oncology . 33, 27, p. 3055-64 10 p.Research output: Contribution to journal › Article › peer-review
- Published
Predicting anthracycline benefit: TOP2A and CEP17 - Not only but also
Daniel Rea, 20 May 2015, In: Journal of Clinical Oncology. 33, 15, p. 1680-1687 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade
Rich Fox, 20 Feb 2015, Journal of Clinical Oncology , 33, 6, p. 550 558 p.Research output: Contribution to specialist publication › Article
- 2014
- Published
Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study
Daniel Rea, 20 Sep 2014, In: Journal of Clinical Oncology. 32, 27, p. 2951-2958Research output: Contribution to journal › Article › peer-review
- Published
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial
Keith Wheatley, 10 Aug 2014, In: Journal of Clinical Oncology . 32, 23, p. 2440-8 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Predictive importance of ulceration on the efficacy of adjuvant interferon-a (IFN): An individual patient data (IPD) meta-analysis of 15 randomized trials in more than 7,500 melanoma patients (pts).
Natalie Rowland & Keith Wheatley, 20 May 2014, In: Journal of Clinical Oncology . 32, 15_suppl, 9067.Research output: Contribution to journal › Article › peer-review
- Published
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis
Claire Palles & 24 others, , 1 Apr 2014, In: Journal of Clinical Oncology . 32, 10, p. 1031-1039 9 p.Research output: Contribution to journal › Article › peer-review
- 2013
- Published
Reply to K.I. Pritchard
Daniel Rea, 10 Dec 2013, In: Journal of Clinical Oncology. 31, 35, p. 4477-4479 3 p.Research output: Contribution to journal › Article › peer-review
- Published
Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid Leukemia
Sylvie Freeman, Robert Hills, Nov 2013, In: Journal of Clinical Oncology.Research output: Contribution to journal › Article › peer-review
- Published
Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial
Robert Hills, Keith Wheatley, 20 Sep 2013, In: Journal of Clinical Oncology . 31, 27, p. 3360-8 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Is uterine serous carcinoma a part of hereditary breast cancer syndrome
Sudha Sundar, 10 Sep 2013, In: Journal of Clinical Oncology . 31, 26Research output: Contribution to journal › Article › peer-review
- Published
Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study
Mark Drayson, 10 Jul 2013, In: Journal of Clinical Oncology . 31, 20, p. 2540-7 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium.
Pamela Kearns, 1 Jul 2013, In: Journal of Clinical Oncology . 31, 19, p. 2460-2468 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Clinical outcomes in patients with castrate-refractory prostate cancer (CRPC) metastatic to bone randomized in the factorial TRAPEZE trial to docetaxel (D) with strontium-89 (Sr89), zoledronic acid (ZA), neither, or both (ISRCTN 12808747)
Lucinda Billingham, Stuart Collins, Emilio Porfiri, 20 Jun 2013, In: Journal of Clinical Oncology . 31, 18_suppl, p. LBA5000Research output: Contribution to journal › Article › peer-review
- Published
Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: An international tamoxifen exemestane adjuvant multinational trial analysis
Daniel Rea, 20 Jun 2013, In: Journal of Clinical Oncology. 31, 18, p. 2257-2264 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Use of serum markers in prediction of survival in the trapeze factorial trial evaluating docetaxel with zoledronic acid, strontium-89, or both in castrate-refractory prostate cancer (CRPC) metastatic to bone
Kaisheng Wen, Sarah Pirrie & Nicholas James, 3 Jun 2013, In: Journal of Clinical Oncology . 31 (supplement), suppl; abstr 5057.Research output: Contribution to journal › Abstract › peer-review
- Published
Impact of gender on efficacy and acute toxicity in standard risk localized (SR) Ewing sarcomas (ES) in the Euro-Ewing99-R1 trial
Keith Wheatley, 20 May 2013, In: Journal of Clinical Oncology . 31, suppl 15, abstr 10031.Research output: Contribution to journal › Article › peer-review
- Published
Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission
Robert Hills, Keith Wheatley, 1 Apr 2013, In: Journal of Clinical Oncology . 31, 10, p. 1293-301 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Muscle invasive bladder cancer in the elderly: Treatment and prognosis in a prospective cohort study
Tom Wright, Adam Devall, Sarah Pirrie, Lucinda Billingham, KK Cheng, Rik Bryan, 20 Feb 2013, In: Journal of Clinical Oncology . 31, 6_suppl, p. 275Research output: Contribution to journal › Article › peer-review
- Published
Results of a Randomized Trial of Chlorambucil Versus Fludarabine for Patients With Untreated Waldenstrom Macroglobulinemia, Marginal Zone Lymphoma, or Lymphoplasmacytic Lymphoma
Dickens Pratt & 1 others, , 20 Jan 2013, In: Journal of Clinical Oncology. 31, 3, p. 301-307Research output: Contribution to journal › Article › peer-review
- 2012
- Published
Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study
Daniel Rea, 20 Dec 2012, In: Journal of Clinical Oncology . 30, 36, p. 4477-84 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia
Robert Hills, Sylvie Freeman, Charles Craddock, Keith Wheatley, 2012, In: Journal of Clinical Oncology . 30, 32, p. 3924-31 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial
Anna Skowronska, Ceri Oldreive, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 2012, In: Journal of Clinical Oncology . 30, 36, p. 4524-4532 9 p.Research output: Contribution to journal › Article › peer-review
- 2011
- Published
Validation Study of a Quantitative Multigene Reverse Transcriptase-Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer.
Richard Gray, Kelly Handley, Laura Magill, 7 Nov 2011, In: Journal of Clinical Oncology.Research output: Contribution to journal › Article
- Published
Health Care Use of Long-Term Survivors of Childhood Cancer: The British Childhood Cancer Survivor Study
Raoul Reulen, Andrew Toogood, Emma Lancashire & Michael Hawkins, 26 Sep 2011, In: Journal of Clinical Oncology. 29, 31, p. 4181-4188 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Quantification of Hormone Receptors to Guide Adjuvant Therapy Choice in Early Breast Cancer: Better Methods Required for Improved Utility
Daniel Rea, 1 Sep 2011, In: Journal of Clinical Oncology. 29, 27, p. 3715-3716 2 p.Research output: Contribution to journal › Article
- Published
Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
Kelly Handley, Laura Magill, Richard Gray, 1 Apr 2011, In: Journal of Clinical Oncology. 29, 10, p. 1261-1270 10 p.Research output: Contribution to journal › Article
- Published
Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial.
Toon Brookes, Lucinda Billingham & Daniel Rea, 21 Mar 2011, In: Journal of Clinical Oncology. 29, 12, p. 1531-1538Research output: Contribution to journal › Article
- Published
Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial
Robert Hills & Keith Wheatley, 1 Feb 2011, In: Journal of Clinical Oncology. 29, 4, p. 369-377 9 p.Research output: Contribution to journal › Article
- Published
Outcome in Renal AL Amyloidosis After Chemotherapy
Jo Bradwell, 1 Feb 2011, In: Journal of Clinical Oncology. 29, 6, p. 674-681 8 p.Research output: Contribution to journal › Article
- Published
Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (Toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer
Gary Middleton, 2011, In: Journal of Clinical Oncology . 29, 19, p. 2667-74 8 p.Research output: Contribution to journal › Article › peer-review
- 2010
- Published
- Published
Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial
Simon Grumett, Michael Langman, 1 Oct 2010, In: Journal of Clinical Oncology. 28, 30, p. 4575-4580 6 p.Research output: Contribution to journal › Article
- Published
Novel uses of coded data in clinical trials
Stuart Collins & Nicholas James, 31 May 2010, In: Journal of Clinical Oncology . 28, no. 15_suppl, p. 6143 6143 p., suppl.6143.Research output: Contribution to journal › Abstract › peer-review
- Published
- Published
Role of Cancer Treatment in Long-Term Overall and Cardiovascular Mortality After Childhood Cancer
Michael Hawkins, 10 Mar 2010, In: Journal of Clinical Oncology. 28, 8, p. 1308-1315 8 p.Research output: Contribution to journal › Article
- Published
How Should We Prevent Hematologic Relapse of Acute Promyelocytic Leukemia? Reply
Keith Wheatley, 1 Feb 2010, In: Journal of Clinical Oncology. 28, 4, p. E63-E64Research output: Contribution to journal › Article
- 2009
- Published
Attempts to Optimize Induction and Consolidation Treatment in Acute Myeloid Leukemia: Results of the MRC AML12 Trial.
Robert Hills & Keith Wheatley, 28 Dec 2009, In: Journal of Clinical Oncology. 28, 4, p. 586-595 10 p.Research output: Contribution to journal › Article
- Published
Bone Marrow Fibrosis and Diagnosis of Essential Thrombocythemia Reply to J. Thiele et al
Keith Wheatley, 1 Dec 2009, In: Journal of Clinical Oncology. 27, 34, p. E222-E223Research output: Contribution to journal › Article
- Published
Survival After Second Primary Neoplasms of the Brain or Spinal Cord in Survivors of Childhood Cancer: Results From the British Childhood Cancer Survivor Study
Aliki Taylor, Raoul Reulen, Emma Lancashire & Michael Hawkins, 1 Dec 2009, In: Journal of Clinical Oncology. 27, 34, p. 5781-5787 7 p.Research output: Contribution to journal › Article
- Published
Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
Deborah Stocken, 20 Nov 2009, In: Journal of Clinical Oncology. 27, 33, p. 5513-5518 6 p.Research output: Contribution to journal › Article
- Published
Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy.
Keith Wheatley, 8 Jun 2009, In: Journal of Clinical Oncology.Research output: Contribution to journal › Article
- Published
Reticulin Accumulation in Essential Thrombocythemia: Prognostic Significance and Relationship to Therapy
Keith Wheatley, 1 Jun 2009, In: Journal of Clinical Oncology. 27, 18, p. 2991-2999 9 p.Research output: Contribution to journal › Article
- Published
Rel A Is an Independent Biomarker of Clinical Outcome in Chronic Lymphocytic Leukemia
Dickens Pratt, Robert Hills, 10 Feb 2009, In: Journal of Clinical Oncology. 27, 5, p. 763-769 7 p.Research output: Contribution to journal › Article
- Published
Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial
Nicholas James, 2009, In: Journal of Clinical Oncology . 27, 32, p. 5431-8 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group
Gary Middleton, 2009, In: Journal of Clinical Oncology . 27, 23, p. 3786-93 8 p.Research output: Contribution to journal › Article › peer-review
- 2008
- Published
New Utility of an Old Marker: Serial -Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy
Philip Johnson, 15 Dec 2008, In: Journal of Clinical Oncology. 27, 3, p. 446-452 7 p.Research output: Contribution to journal › Article
- Published
Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: Report by the Colorectal Adenoma/Carcinoma Prevention Programme 2
Eamonn Maher, Jonathan Mathers, 1 Jul 2008, In: Journal of Clinical Oncology. 26, 20, p. 3434-3439 6 p.Research output: Contribution to journal › Article
- Published
EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer
Gary Middleton, 2008, In: Journal of Clinical Oncology . 26, 14, p. 2311-9 9 p.Research output: Contribution to journal › Article › peer-review
- 2007
- Published
Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients.
Natalie Rowland, Becky Harrison & Keith Wheatley, 1 Dec 2007, In: Journal of Clinical Oncology. 25, 34, p. 5426-34 9 p.Research output: Contribution to journal › Article
- Published
Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion
Judy Powell, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 1 Dec 2007, In: Journal of Clinical Oncology. 25, 34, p. 5448-57 10 p.Research output: Contribution to journal › Article
- Published
Rational Selection of Patients for Antibacterial Prophylaxis After Chemotherapy
Lucinda Billingham & Neil Steven, 20 Oct 2007, In: Journal of Clinical Oncology. 25, 30, p. 4821-4828 8 p.Research output: Contribution to journal › Article
- Published
End Points for Colon Cancer Adjuvant Trials: Observations and Recommendations Based on Individual Patient Data From 20,898 Patients Enrolled Onto 18 Randomized Trials From the ACCENT Group
Richard Gray, 10 Oct 2007, In: Journal of Clinical Oncology. 25, 29, p. 4569-4574 6 p.Research output: Contribution to journal › Article
- Published
Does adjuvant vaccine therapy really have activity in malignant melanoma?
Keith Wheatley, Natalie Rowland, 1 Oct 2007, In: Journal of Clinical Oncology. 25, 29, p. 4693-4693 1 p.Research output: Contribution to journal › Article
- Published
Role of Lymphangiogenesis in Cancer
Sudha Sundar, 13 Aug 2007, In: Journal of Clinical Oncology. 25, 27, p. 4298-4307 10 p.Research output: Contribution to journal › Article
- Published
The National Epirubicin Adjuvant Trial (NEAT) and Scottish Cancer Trials Breast Group (SCTBG) br9601 randomized phase III adjuvant early breast cancer trials: the updated definitive joint analysis
Sarah Bathers, 20 Jun 2007, In: Journal of Clinical Oncology . 25, 18 suppl, 1 p., 534.Research output: Contribution to journal › Abstract
- Published
Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control study
Michael Hawkins, 11 Jun 2007, In: Journal of Clinical Oncology. 25, p. 2833-2839 7 p.Research output: Contribution to journal › Article
- Published
Randomised trial of exercise therapy in women treated for breast cancer
Amanda Daley & Andrea Roalfe, 1 May 2007, In: Journal of Clinical Oncology. 25, p. 1713-1721 9 p.Research output: Contribution to journal › Article
- Published
Suicide among survivors of childhood cancer
Michael Hawkins, 1 Jan 2007, In: Journal of Clinical Oncology. 2007, 25, p. 731-732 2 p.Research output: Contribution to journal › Article
- Published
Tolerability and efficacy of classical CMF (cCMF) using oral cyclophosphamide (OC) vs intravenous cyclophosphamise (IVC) in early stage breast cancer: A non-randomised comparison of patients (pts) treated in the National Epirubicin Adjuvant Trial (NEAT) 40th Annual American Society of Slinical Oncology meeting. New Orleans, Louisiana USA June 2004
Sarah Bathers, 1 Jan 2007, In: Journal of Clinical Oncology . 22 (14), p. 595SResearch output: Contribution to journal › Article
- 2006
- Published
Problems with up-front randomization in clinical trials
Keith Wheatley, Robert Hills, 6 Nov 2006, In: Journal of Clinical Oncology. 24, p. 5471-5472 2 p.Research output: Contribution to journal › Letter
- Published
Advanced breast cancer patients' perceptions of decision making for palliative chemotherapy
Beth Grunfeld, 2006, In: Journal of Clinical Oncology . 24, 7, p. 1090-8 9 p.Research output: Contribution to journal › Article › peer-review
- 2005
- Published
Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia
Charles Craddock, Gulnaz Begum, 28 Nov 2005, In: Journal of Clinical Oncology. 23, 36, p. 9387-9393 7 p.Research output: Contribution to journal › Article › peer-review
- Published
Early mortality after diagnosis of multiple myeloma: Analysis of patients endered onto the United Kingdom Medical Research Council trials between 1980 and 2002
Gulnaz Begum, Janet Dunn & Mark Drayson, 28 Nov 2005, In: Journal of Clinical Oncology. 23, p. 9219-9226 8 p.Research output: Contribution to journal › Article
- Published
An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results
Philip Johnson, 1 Nov 2005, In: Journal of Clinical Oncology. 23, p. 8041-8047 7 p.Research output: Contribution to journal › Article
- Published
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies
Richard Gray, 31 Oct 2005, In: Journal of Clinical Oncology. 23, p. 8664-8670 7 p.Research output: Contribution to journal › Article
- Published
Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of haematologic malignancies: An individual patient data meta-analysis of nine randomised trials
Keith Wheatley & Robert Hills, 6 Jun 2005, In: Journal of Clinical Oncology. 23, p. 5074-5087 14 p.Research output: Contribution to journal › Article
- Published
Adjuvant interferon therapy for melanoma
Keith Wheatley, Natalie Rowland, 7 Feb 2005, In: Journal of Clinical Oncology. 23, p. 2431 1 p.Research output: Contribution to journal › Letter
- Published
Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: A trial of the National Cancer Institute of Canada Clinical Trials Group
Christopher Poole, 7 Feb 2005, In: Journal of Clinical Oncology. 23, 9, p. 1859-1866 8 p.Research output: Contribution to journal › Article
- Published
Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic leukaemia once treatment is initiated
Dickens Pratt, 31 Jan 2005, In: Journal of Clinical Oncology. 23, p. 1514-1521 8 p.Research output: Contribution to journal › Article
- Published
WARP - A multicentre prospective randomised controlled trial (RCT) of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs)
Annie Young, Gulnaz Begum, Lucinda Billingham, Daniel Rea, Keith Wheatley, 1 Jan 2005, In: Journal of Clinical Oncology. 23, p. 16SResearch output: Contribution to journal › Abstract
- 2004
- Published
Malignant breast tumours following radiotherapy for a first cancer during childhood
Michael Hawkins, 31 Dec 2004, In: Journal of Clinical Oncology. 23, p. 197-204 8 p.Research output: Contribution to journal › Article
- Published
Virus directed enzyme prodrug therapy: Intratumoural administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer
Daniel Palmer, Vivien Mautner, Stefan Hubscher, Seran Hill, Peter Searle, Lawrence Young, Nicholas James, 29 Mar 2004, In: Journal of Clinical Oncology. 22, p. 1546-1552 7 p.Research output: Contribution to journal › Article
- Published
Azacitidine induces demethylation of the Epstein-Barr virus genome in tumours
Philip Johnson, 1 Jan 2004, In: Journal of Clinical Oncology. 22, p. 1373-1381 9 p.Research output: Contribution to journal › Article
- Published
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy
Philip Johnson, 1 Jan 2004, In: Journal of Clinical Oncology. 22, p. 927-934 8 p.Research output: Contribution to journal › Article
- Published
Pathologic complete response and survival advantage in esophageal cancer: Old news
Deborah Stocken, 1 Jan 2004, In: Journal of Clinical Oncology. 22, p. 2513-2514 2 p.Research output: Contribution to journal › Article
- Published
Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: Therapeutic monitoring with plasma Epstein-Barr virus DNA
Philip Johnson, 1 Jan 2004, In: Journal of Clinical Oncology. 22, p. 3053-3060 8 p.Research output: Contribution to journal › Article
- Published
A randomized trial comparing defined-duration with continuous irinotecan until disease progression in fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer
Gary Middleton, 2004, In: Journal of Clinical Oncology. 22, 15, p. 3023-31 9 p.Research output: Contribution to journal › Article › peer-review
- 2003
- Published
Adjuvant interferon in high-risk melanoma: The AIM HIGH Study-United Kingdom Coordinating Committee on cancer research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma
Keith Wheatley, Natalie Rowland, 2 Dec 2003, In: Journal of Clinical Oncology. 22, p. 53-61 9 p.Research output: Contribution to journal › Article
- Published
Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: Pathologic complete response induced by chemotherapy leads to long-term survival
Deborah Stocken, 24 Sep 2003, In: Journal of Clinical Oncology. 21, p. 4009-4015 7 p.Research output: Contribution to journal › Article
- Published
Older age is an adverse prognostic factor in Stage I favourite histology Wilms tumour treated with Vincristine mono-chemotherapy: A UK Children's Cancer Study group Study
Sep 2003, In: Journal of Clinical Oncology. 21, 17, p. 3269-3275 7 p.Research output: Contribution to journal › Article › peer-review
- Published
Phase II study of the efficacy and safety of cisplatin-epinephrine injectable gel administered to patients with unresectable hepatocellular carcinoma
Philip Johnson, 15 Feb 2003, In: Journal of Clinical Oncology. 21, 4, p. 652-658 7 p.Research output: Contribution to journal › Article
- 2002
- Published
Need for a quantitative meta-analysis of trials of adjuvant interferon in melanoma
Keith Wheatley, Natalie Rowland, 1 Oct 2002, In: Journal of Clinical Oncology. 20, 19, p. 4120-4122 3 p.Research output: Contribution to journal › Letter
- Published
Role of non-myeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies
Alan Parker, Ronjon Chakraverty, Charles Craddock, 1 Oct 2002, In: Journal of Clinical Oncology. 20, 19, p. 4022-4031 10 p.Research output: Contribution to journal › Article › peer-review
- Published
ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumours: Results of a Phase I trial
Lisette Hammond, David Ferry, Phil Murray, 1 May 2002, In: Journal of Clinical Oncology. 20, 9, p. 2240-2250 11 p.Research output: Contribution to journal › Article
- Published
Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a Phase III randomised trial
Philip Johnson, 15 Apr 2002, In: Journal of Clinical Oncology. 20, 8, p. 2038-2044 7 p.Research output: Contribution to journal › Article
- Published
Hepatic drug targeting: Phase I evaluation of polymer-bound doxorubicin
Leonard Seymour, David Ferry, Annie Young & David Kerr, 15 Mar 2002, In: Journal of Clinical Oncology. 20, 6, p. 1668-1676 9 p.Research output: Contribution to journal › Article
- Published
Mutations of hMSH2 and hMLH1 in patients with suspected hereditary non-polyposis colorectal cancer (HNPCC)
Emilio Porfiri, 1 Mar 2002, In: Journal of Clinical Oncology. 20, p. 1203-1208 6 p.Research output: Contribution to journal › Article
- Published
Missense mismatch repair gene alterations, microsatellite instability and hereditary nonpolyposis colorectal cancer
Emilio Porfiri, 1 Jan 2002, In: Journal of Clinical Oncology. 20, p. 3178-3179 2 p.Research output: Contribution to journal › Letter
- Published
ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial
David Ferry, Phil Murray, 2002, In: Journal of Clinical Oncology. 20, 9, p. 2240-50 11 p.Research output: Contribution to journal › Article › peer-review
- 2001
- Published
Ascertainment of the incidence of Beckwith-Wiedemann syndrome in the National Wilms Tumor Study Group
Richard Grundy, 1 Jan 2001, In: Journal of Clinical Oncology. 19, 2, p. 593-593 1 p.Research output: Contribution to journal › Article
- Published
Marimastat as first line therapy for patients with unresectable pancreatic cancer - A randomised trial
Simon Bramhall, 1 Jan 2001, In: Journal of Clinical Oncology. 19, 15, p. 3447-3455 9 p.Research output: Contribution to journal › Article
- 2000
- Published
Quality of life in non-small-cell lung cancer
Lucinda Billingham, Apr 2000, In: Journal of Clinical Oncology . 18, 8, p. 1802Research output: Contribution to journal › Article › peer-review
- 1999
- Published
Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life
Lucinda Billingham, David Ferry, Oct 1999, In: Journal of Clinical Oncology . 17, 10, p. 3188-94 7 p.Research output: Contribution to journal › Article › peer-review